QNRX
$7.94-0.06 (-0.74%)
Quoin Pharmaceuticals, Ltd., a late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Quoin Pharmaceuticals, Ltd., a late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lo...
Recent News
Quoin Pharmaceuticals Insider Ups Holding By 1,515,200% During Year
Looking at Quoin Pharmaceuticals, Ltd.'s ( NASDAQ:QNRX ) insider transactions over the last year, we can see that...
Top Midday Gainers
Quoin Pharmaceuticals (QNRX) shares soared 126% amid heavy trading intraday after the company said F
Quoin Pharmaceuticals Shares Jump After Announcing $104.5 Million Private Placement
Quoin Pharmaceuticals (QNRX) shares jumped nearly 170% in recent Friday trading after the company sa
Quoin Pharmaceuticals Says US FDA Clears Second Netherton Syndrome Pivotal Study
Quoin Pharmaceuticals (QNRX) said Thursday that it has received US Food and Drug Administration clea